Abstract
During the last decade, several new antidepressants have been introduced into clinical practice. The authors examine whether these new drugs have real clinical advantages. In addition, the major differences between the different classes of antidepressants, will be summarized. The article aims to help psychiatrists in their clinical decision which antidepressant agent would be 'ideal' for a given patient.
| Translated title of the contribution | Treatment of depressive disorders: Clinical advantages and differential indications for new antidepressant drugs |
|---|---|
| Original language | German |
| Journal | Psycho |
| Volume | 27 |
| Issue number | 3 |
| Pages (from-to) | 168-173 |
| Number of pages | 6 |
| ISSN | 0340-7845 |
| Publication status | Published - 2001 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being -
SDG 10 Reduced Inequalities
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)
Fingerprint
Dive into the research topics of 'Treatment of depressive disorders: Clinical advantages and differential indications for new antidepressant drugs'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver